This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Prostate Cancer Medical Websites: Friend Or Foe?

How Prostate Cancer Websites Stack Up

Loyola University Medical Center explored 62 different prostate cancer websites, finding that most are written above a 12th-grade reading level. Since one-third of Americans read below a high-school level, that presents a significant patient wellness challenge. As a general guideline, the U.S. National Institutes of Health suggest a fourth- to sixth-grade reading level for patient education materials, though few seem to heed that advice.

Striking a balance between medical expertise and patient-speak online presents a significant challenge for doctors. "In person, patients can ask questions and even when they don't we can read the uncertainly on their faces and know that further clarification is needed," says Dr. Samadi. "Whether in person or online, we have a responsibility to put ourselves in the patient's shoes and educate them in meaningful ways."

As a general rule, patients should seek health information from trusted sources such as large hospitals and experienced physicians and surgeons. Look for recommendations and advice backed by current medical research and well-recognized centers of excellence. "Patients should be as discerning online as they would be in person," urges Dr. Samadi. "Some websites are very useful, but if patients are unsure about something they read or feel they need more clarification, there's no substitute for the personal counsel of a specialist."

Dr. Samadi works to share prostate cancer information that's meaningful and useful to patients and their families. His primary site, www.roboticoncology.com, is even translated into six additional languages, including Hebrew.



David Samadi, MD has performed more than 4,000 successful robotic prostatectomy procedures at New York's Mount Sinai Medical Center where he serves as Vice Chairman, Department of Urology and Chief of Robotics and Minimally Invasive Surgery.



Related Links:

http://www.roboticoncology.com     http://www.smart-surgery.com

Related Videos:



2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs